CNS Pharma Raises $22.5M in Private Offering

CNS Pharmaceuticals, Inc. announced a private placement with institutional investors, raising approximately $22.5 million in gross proceeds. The offering included 650,000 shares of common stock at $2.30 per share and 9,143,479 pre-funded warrants at $2.299 per warrant. The company intends to use the net proceeds to identify, acquire, and advance new assets, as well as for working capital and general corporate purposes. Additionally, Jerzy (George) Gumulka resigned from the Board of Directors, and Michal Fisher was appointed as an independent director.